Your session is about to expire
What is Cardura Xl
Approved as Treatment by the FDA
Doxazosin, commonly known as Cardura, is approved by the FDA for 1 uses which include Hypertensive disease .Effectiveness
When to interrupt dosage
The recommended quantity of Cardura Xl is contingent upon the determined condition, such as Enlarged Prostate, Ureteric calculus and Hypertensive disease. The dose differs as per the technique of delivery noted in the table below.Warnings
Cardura Xl has one contraindication and should not be employed together with the conditions listed in the below table.Cardura Xl ContraindicationsCardura Xl Novel Uses: Which Conditions Have a Clinical Trial Featuring Cardura Xl?
39 active clinical trials are presently researching the potential of Cardura Xl to remedy Enlarged Prostate, Ureteric calculus and Hypertensive disease.Cardura Xl Reviews: What are patients saying about Cardura Xl?
Patient Q&A Section about cardura xl
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What are side effects of Cardura?
"You may experience dizziness, lightheadedness, drowsiness, or unusual tiredness. If any of these effects last or get worse, tell your doctor or pharmacist promptly. To reduce the risk of dizziness and lightheadedness, get up slowly when rising from a sitting or lying position."
When should I take Cardura XL?
"You should take this medication according to your doctor's instructions, typically once a day with breakfast. Doxazosin can lower your blood pressure suddenly, which might make you feel dizzy or faint. These effects usually happen a few hours after taking the medication."
What is Cardura XL used for?
"Cadura XL is used to help with issues urinating associated with benign prostatic hyperplasia (BPH) for both those who have high blood pressure and those who don't."
Is Cardura XL the same as doxazosin?
"Cardura XL is a medication used to treat hypertension or improve urination in men with benign prostatic hyperplasia. It works by blocking alpha-adrenergic receptors."